Establishment and application of drug use evaluation standard of somatostatin for injection
10.12173/j.issn.1005-0698.202306024
- VernacularTitle:注射用生长抑素药物利用评价标准的建立及应用
- Author:
Jiehong ZHANG
1
;
Huiya CAI
;
Liping CAI
;
Yibo HAN
;
Jinhua ZHANG
Author Information
1. 北海市人民医院药剂科(广西北海 536000)
- Keywords:
Somatostatin for injection;
Drug use evaluation standard;
Rational drug use
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(4):381-387
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish the drug use evaluation(DUE)standard of somatostatin and evaluate the rationality of its clinical use,so as to provide a reference for the rationally clinical application of somatostatin.Methods Based on the specification of somatostatin for injection,related guidelines and literature,DUE standard was established.Evaluate the rationality and standardization of the use of somatostatin for injection at Beihai People's Hospital from January 2021 to December 2021 based on the established DUE standards.Results A total of 407 patients were included,with a medication reasonable rate of 94.84％.The irrational use of drug included unreasonable indications(13 cases,3.19％),unreasonable drug use frequency(7 cases,1.72％),and unreasonable drug interactions(1 case,0.25％).Conclusion The somatostatin for injection DUE standard established is feasible and practical.The clinical application of somatostatin for injection in this hospital is basically reasonable,but there are still some irrational use of somatostatin,which should be strengthened for intervention.
